By Christopher Cole ( November 10, 2021, 7:35 PM EST) -- Two pharma companies must sell off their stakes in a pair of generic drugs and seek Federal Trade Commission approval for any future entry into those drug markets in order to complete their $210 million merger, the FTC said Wednesday....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.